In the main, people have complimented my weight loss, but more recently some have openly suggested that it was because of ...

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat Parkinson's disease. Despite ...

People with type 2 diabetes who used semaglutide (Ozempic) versus other drugs had a lower risk of Alzheimer's disease and ...

A rigorous study that randomly assigned Parkinson’s patients to take exenatide, a relative of Ozempic, showed absolutely no benefit or slowing of the course of the degenerative disease after 96 ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also cause pregnancy complications and harm some users.

I was just a baby scientist when I discovered the hormone that made Ozempic possible. I had no idea how life-changing—and ...

Canadian endocrinologist Daniel J. Drucker — a diabetes treatment pioneer whose work paved the way for Ozempic — is sharing what's next for these obesity and diabetes drugs.

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the secret to staving off Alzheimer’s, too.

The ingredient semaglutide, used in weight management and diabetes treatments Wegovy and Ozempic, is now the focus of clinical trials to ascertain its effectiveness in Alzheimer's and Parkinson's ...

Hungarian-born scientist Bence Ölveczky fears his lab's groundbreaking work on brain function and motor skills will end as federal funding disappears.